MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

The latest financial statement is for the quarter ending 2025-09-30.

Cash Flow Overview

Free Cash flow
-$26,577K

Unit: Thousand (K) dollars (except for numbers of shares and EPS)
Cash Flow
2025-09-30
2025-06-30
Net loss
-32,250 -71,691
Depreciation and amortization
3,227 6,611
Stock-based compensation
4,861 14,535
Accretion and amortization of premiums and discounts on investments, net
810 1,915
Deferred revenue
4 -393
Change in fair value of stock price appreciation milestones
90 -207
(gain) loss on disposal of property and equipment
0 36
Accounts receivable
-713 -2,144
Prepaid expenses and other assets
-1,026 -3,139
Accounts payable and accrued expenses
-550 -9,342
Right-of-use assets and lease liabilities, net
-685 -1,241
Net cash used in operating activities
-24,374 -58,396
Proceeds from sale of property and equipment
3 122
Purchases of property and equipment
2,203 2,558
Purchases of investments
57,975 99,437
Maturities of investments
81,447 164,137
Net cash provided by (used in) investing activities
21,272 62,264
Issuance of common stock from equity incentive plans, net of issuance costs
0 0
Proceeds from public offering of common stock, net of issuance costs
0 0
Proceeds from issuance of pre-funded warrants, net of issuance costs
0 0
Proceeds from ft819 cirm award
0 0
Proceeds from ft836 cirm award
-2,475 -1,325
Net cash provided by financing activities
2,475 1,325
Net change in cash, cash equivalents and restricted cash
-627 5,193
Cash and cash equivalents at beginning of period
46,283 -
Cash and cash equivalents at end of period
50,849 -
Unit: Thousand (K) dollars

Time Plot

Show the time plot by selecting a row from the table.

FATE THERAPEUTICS INC (FATE)

FATE THERAPEUTICS INC (FATE)